InvestSMART

Holista Colltech Limited (ASX:HCT)

ALERT: Price-sensitive ASX Announcement for HCT
Current share price for HCT : $0.043 -0.037 (-46.25%)+
Announcement
Release
30 Jul 2026 8:29AM
Price at Release
$0.080
Full Release
download
Summary
Holista Colltech Limited reported an increase in group revenue to A$1.50 million for the quarter ended 30 June 2026. Customer receipts improved, largely due to enhanced collections and deposits, amounting to A$1.48 million. The quarter experienced significant operating cash outflows, primarily attributed to a US$1.0 million payment related to the ProImmune legal settlement, resulting in a net outflow of A$1.29 million. However, excluding this one-off payment, underlying cash outflows improved through better inventory and cost management. The company also reported investment cash inflows of A$88,000 from fixed deposits and a net cash outflow of A$170,000 in financing activities. Ending the quarter with A$526,000 in cash, Holista plans to use its A$1.45 million unused financing facilities to support operations and considers raising additional capital if needed, as it continues to focus on financial management and ongoing operations.
Key Points
  • Holista Colltech Limited reported a revenue increase of 0.8% to approximately A$1.50 million for the quarter ended 30 June 2026.
  • Customer receipts rose by 12.9% to A$1.48 million, attributed to improved collections, debt recoveries, and customer deposits.
  • A significant operating cash outflow of A$1.29 million occurred due to a US$1.0 million payment for the ProImmune legal settlement.
  • Underlying operating cash outflows improved due to lower inventory purchases, reduced staff costs, and cost management.
  • Investment cash inflows were primarily from the maturity and withdrawal of fixed deposits, totaling A$88,000.
  • Financing activities resulted in a net cash outflow of A$170,000 due to loan repayments and banker acceptances.
  • The company ended the quarter with A$526,000 in cash and cash equivalents, down from A$1.94 million at the start of the quarter.
  • Holista plans to utilize A$1.45 million in unused financing facilities for future operations and considers potential capital raising.
  • The company expects to continue operations effectively, supported by non-recurring nature of ProImmune payments and available funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.